Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty.
about
Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Outcome of the HORIZONS-AMI tr ...... rction undergoing angioplasty.
@ast
Outcome of the HORIZONS-AMI tr ...... rction undergoing angioplasty.
@en
type
label
Outcome of the HORIZONS-AMI tr ...... rction undergoing angioplasty.
@ast
Outcome of the HORIZONS-AMI tr ...... rction undergoing angioplasty.
@en
prefLabel
Outcome of the HORIZONS-AMI tr ...... rction undergoing angioplasty.
@ast
Outcome of the HORIZONS-AMI tr ...... rction undergoing angioplasty.
@en
P2860
P921
P356
P1476
Outcome of the HORIZONS-AMI tr ...... rction undergoing angioplasty.
@en
P2093
Ashish Shah
Dmitriy N Feldman
P2860
P304
P356
10.2147/VHRM.S23491
P407
P577
2012-02-27T00:00:00Z